Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2)

GLIA

Volumn 41, Issue 1, 2003, Pages 15-24

  Lee, Woo Jong ^a   Shin, Chan Young ^a   Yoo, Byoung Kwon ^a   Ryu, Jae Ryun ^a   Choi, Eui Yul ^b   Cheong, Jae Hoon ^c   Ryu, Jong Hoon ^d   Ko, Kwang Ho ^a  

^a Seoul National University   (South Korea)

^b Hallym University   (South Korea)

^c Sahmyook University   (South Korea)

^d Kyung Hee University   (South Korea)

Author keywords

Erk1 2; Lipopolysaccharide; Matrix metalloproteinase; PKC; Primary astrocytes

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; GELATIN; GELATINASE A; GELATINASE B; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITOMETRY; ENZYME ACTIVATION; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ASTROCYTES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATORS; ENZYME INDUCTION; ENZYME INHIBITORS; FLAVONOIDS; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037259961     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10131     Document Type: Article

References (56)

1. Anthony DC, Miller KM, Fearn S, Townsend MJ, Opdenakker G, Wells GM, Clements JM, Chandler S, Gearing AJ, Perry VH. 1998. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol 87:62-72.
2. Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. 2000. Role for matrix metalloproteinase-9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20:1681-1682.
3. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH. 2001. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21:7724-7732.
4. Benveniste EN, Kwon J, Chung WJ, Sampson J, Pandya K, Tang LP. 1994. Differential modulation of astrocyte cytokine gene expression by TGF-beta. J Immunol 153:5210-5221.
5. Bhat NR, Z hang P, Lee JC, Hogan EL. 1998. Extracellular signal-regulated kinse and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18:1633-1641.
6. Cao J, Rehemtulla A, Bahou W, Zucker S. 1996. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J Biol Chem 271:30174-30180.
7. Chambaut-Guerin AM, Herigault S, Rouet-Benzineb P, Rouher C, Lafuma C. 2000. Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: relevance to neuronal differentiation. J Neurochem 74:508-517.
8. Chauvet N, Palin K, Verrier D, Poole S, Dantzer R, Lestage J. 2001. Rat microglial cells secrete predominantly the precursor of interleukin-1 beta in response to lipopolysaccharide. Eur J Neurosci 14:609-617.
9. Cho A, Graves J, Reidy MA. 2000. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20:2527-2532.
10. Dean DF, Bochsler PN, Carroll RC, Olchowy TW, Neilsen NR, Slauson DO. 1998. Signaling pathways for tissue factor expression in lipopolysaccharide-stimulated bovine alveolar macrophages. Am J Vet Res 59:445-451.
11. Del Bigio MR, Tchelingerian JL, Jacque CM. 1999. Expression of extracellular matrix degrading enzymes during migration of xenografted brain cells. Neuropathol Appl Neurobiol 25:54-62.
12. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689.
13. Ferguson TA, Muir D. 2000. MMP-2 and MMP-9 increase the neuritepromoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol Cell Neurosci 16:157-167.
14. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75:181-189.
15. Galve-Roperh I, Haro A, Diaz-Laviada I. 1997a. Induction of nerve growth factor synthesis by sphingomyelinase and ceramide in primary astrocyte cultures. Brain Res Mol Brain Res 52:90-97.
16. Galve-Roperh I, Haro A, Diaz-Laviada I. 1997b. Ceramide-induced translocation of protein kinase C zeta in primary cultures of astrocytes. FEBS Lett 415:271-274.
17. Genersch E, Hayess K, Neuenfeld Y, Haller H. 2000. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci 113(Pt 23):4319-4330.
18. Gijbels K, Proost P, Masure S, Carton H, Billiau A, Opdenakker G. 1993. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 36:432-440.
19. Gijbels K, Galardy RE, Steinman L. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 94:2177-2182.
20. Gingrich MB, Traynelis SF. 2000. Serine proteases and brain damage: is there a link? Trends Neurosci 23:399-407.
21. Gottschall PE, Yu X. 1995. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 64:1513-1520.
22. Guha M, Mackman N. 2001. LPS induction of gene expression in human monocytes. Cell Signal 13:85-94.
23. Hagg T, Muir D, Engvall E, Varon S, Manthorpe M. 1989. Lamininlike antigen in rat CNS neurons: distribution and changes upon brain injury and nerve growth factor treatment. Neuron 3:721-732.
24. Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, del Zoppo GJ. 1999. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19:624-633.
25. Hernandez MR, Pena JD, Selvidge JA, Salvador-Silva M, Yang P. 2000. Hydrostatic pressure stimulates synthesis of elastin in cultured optic nerve head astrocytes. Glia 32:122-136.
26. Joseph CK, Wright SD, Bornmann WG, Randolph JT, Kumar ER, Bittman R, Liu J, Kolesnick RN. 1994. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramideactivated protein kinase in myeloid cells. J Biol Chem 269:17606-17610.
27. Kieseier BC, Seifert T, Giovannoni G, Hartung HP. 1999. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology 53:20-25.
28. Korzus E, Nagase H, Rydell R, Travis J. 1997. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem 272:1188-1196.
29. Maeda A, Sobel RA. 1996. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol 55:300-309.
30. Makela M, Salo T, Larjava H. 1998. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? Biochem Biophys Res Comm 253:325-335.
31. Matrisian LM. 1994. Matrix metalloproteinase gene expression. Ann NY Acad Sci 732:42-50.
32. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F. 1997. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 17:583-591.
33. Mayer AMS, Hall M, Fay MJ, Lamar P, Pearson C, Prozialeck WC, Lehmann VKB, Jacobson PB, Romanic AM, Uz T, Manev H. 2001. Effect of a short-term in vitro exposure to the marine toxin domoic acid on viability, tumor necrosis factor-alpha, matrix metalloproteinase-9 and superoxide anion release by rat neonatal microglia. BMC Pharmacol 1:7-19.
34. Muir EM, Adcock KH, Morgenstern DA, Clayton R, von Stillfried N, Rhodes K, Ellis C, Fawcett JW, Rogers JH. 2002. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Mol Brain Res 100:103-117.
35. Nakamura S, Todo T, Motoi Y, Haga S, Aizawa T, Ueki A, Ikeda K. 1999. Glial expression of fibroblast growth factor-9 in rat central nervous system. Glia 28:53-65.
36. Oh LYS, Larsen PH, Krekoski CA, Edwards DR, Donovan F, Werb Z, Yong VW. 1999. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19:8464-8475.
37. Perides G, Tanner-Brown LM, Eskildsen MA, Klempner MS. 1999. Borrelia burgdorferi induces matrix metalloproteinases by neural cultures. J Neurosci Res 58:779-790.
38. Pfefferkorn T, Wiessner C, Allegrini PR, Staufer B, Vosko MR, Liebetrau M, Bueltemeier G, Kloss CU, Hamann GF. 2000. Plasminogen activation in experimental permanent focal cerebral ischemia. Brain Res 882:19-25.
39. Prayoonwiwat N, Rodriguez M. 1993. The potential for oligodendrocyte proliferation during demyelinating disease. J Neuropathol Exp Neurol 52:55-63.
40. Ravanti L, Heino J, Lopez-Otin C, Kahari V. 1999. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem 274:2446-2455.
41. Roher AE, Kasunic TC, Woods AS, Cotter RJ, Ball MJ, Fridman R. 1994. Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A. Biochem Biophys Res Comm 205:1755-1761.
42. Rosenberg GA, Kornfeld M, Estrada E, Kelley RO, Liotta LA, StetlerStevenson WG. 1992. TIMP-2 reduces proteolytic opening of bloodbrain barrier by type IV collagenase. Brain Res 576:203-207.
43. Rosenberg GA, Estrada EY, Dencoff JE. 1998. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29:2189-2195.
44. Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, Gearing A. 2001. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893:104-112.
45. Schumann RR, Pfeil D, Freyer D, Buerger W, Lamping N, Kirschning CJ, Goebel UB, Weber JR. 1998. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes. Glia 22:295-305.
46. Shin CY, Choi JW, Ryu JR, Ryu JH, Kim W, Kim H, Ko KH. 2001. Immunostimulation of rat primary astrocytes decreases intracellular ATP level. Brain Res 902:198-204.
47. Thon N, Haas CA, Rauch U, Merten T, Fassler R, Frotscher M, Deller T. 2000. The chondroitin sulphate proteoglycan brevican is upregulated by astrocytes after entorhinal cortex lesions in adult rats. Eur J Neurosci 12:2547-2558.
48. Tomasek JJ, Halliday NL, Updike DL, Ahern-Moore JS, Vu TK, Liu RW, Howard EW. 1997. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem 272:7482-7487.
49. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
50. Uhm JH, Dooley NP, Oh LYS, Yong VW. 1998. Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22:53-63.
51. Wright SD, Kolesnick RN. 1995. Does endotoxin stimulate cells by mimicking ceramide? Immunol Today 16:297-302.
52. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21:75-80.
53. Zeigler ME, Chi Y, Schmidt T, Varani J. 1999. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 180:271-284.
54. Zhang P, Miller BS, Rosenzweig SA, Bhat NR. 1996. Activation of C-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J Neurosci Res 46:114-121.
55. Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M. 2002. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 22:379-392.
56. Zuo J, Ferguson TA, Hernandez YJ, Stetler-Stevenson WG, Muir D. 1998. Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci 18:5203-5211.